🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Tablet(s) Serving Size
60 Servings
Other Combinations Product Type
50% Evidence Coverage

Supplement Facts — Evidence Check

Calcium
22 mg (2% DV)
3 mg
📊 Market median: 3.0mg (984 products) 📚 236 studies (Tier A: 2, B: 109)
This product: 3mg UL 10mg

Other Ingredients

Microcrystalline Cellulose Croscarmellose Sodium Stearic Acid Magnesium Stearate Silica

Label Claims — Verification

All Other
All Other (100% of products) Structure/Function (86% of products) Nutrient (7% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating) Gluten Free

Product Information

📋 Directions for Use

Directions: As a Dietary Supplement, take one (1) tablet before bedtime in any 24 hour period.

⚠️ Warnings & Precautions

Not for use by children, teenagers, or pregnant or lactating women. If you are under medical supervision, or have an autoimmune disease, diabetes, a depressive disorder, epilepsy, leukemia or a lymphoproliferative disorder, or are taking tranquilizers, sedatives, an MAO inhibitor drug (or for 14 days after stopping MAOI therapy), corticosteroids such as cortisol, or prednisone, blood thinners or blood pressure medications, consult a health care professional before taking this product.

Keep out of the reach of children.

Warning: Do not use if you have a hypersensitivity to any ingredient.

Do not use if any tamper evident seal is missing or broken.

To report a serious adverse event contact: 1-800-367-3395.

Warnings: Use only at bedtime. For adult use only.

Not for use by children, teenagers, or pregnant or lactating women.

🧪 Formulation Notes

Gluten Free No artificial colorings, flavorings, preservatives or sweeteners

Additional Information

Store in a cool, dry place.

breckenridge A Towa company

Product Details

UPC / SKU 3 51991 01406 5
DSLD Entry Date 2020-07-23
Product Type Other Combinations
Form Tablet or Pill
DSLD ID 230150
Data Updated 2026-04-11

Research Evidence

291 Research Sources
55 Avg Quality Score
129 Meta Analysis
93 Systematic Review
51 Rct
11 Clinical Trial
2 Other
2 Regulatory Source
1 Openfda Safety
A Interventions for preventing delirium in hospitalised non-ICU patients
Meta Analysis The Cochrane database of systematic reviews 2016
A Melatonin for preoperative and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2020
A Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ open 2022
B Pharmacological interventions for prevention of weight gain in people with schizophrenia
Meta Analysis The Cochrane database of systematic reviews 2022
B Melatonin for pre- and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2015
B Prevention of depression in adults with long-term physical conditions
Meta Analysis The Cochrane database of systematic reviews 2021
B Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis
Systematic Review Lancet (London, England) 2022
B Does melatonin administration reduce the incidence of postoperative delirium in adults? Systematic review and meta-analysis
Meta Analysis BMJ open 2023
B Second-generation antidepressants for preventing seasonal affective disorder in adults
Meta Analysis The Cochrane database of systematic reviews 2015
B Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries
Meta Analysis The Cochrane database of systematic reviews 2021
View all evidence for Melatonin →

Compare Similar Products

View all Melatonin products →